secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rani Therapeutics Holdings, Inc. (RANI)
CIK:        0001856725
Form:       8-K
Filed at:   2025-06-26T23:59:59+00:00
Accession:  0000950170-25-090384
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rani Therapeutics receives Nasdaq bid price deficiency notice; 180-day cure ends Dec 17
--------------------------------------------------------------------------------

- Received Nasdaq notice on June 20, 2025 for non-compliance with $1.00 minimum bid price (30 consecutive business days below $1.00).
- Must regain compliance by December 17, 2025 by maintaining a closing bid price of at least $1.00 for 10 consecutive business days.
- If not cured, may transfer to Nasdaq Capital Market for an additional 180-day period, subject to meeting other initial listing standards.
- Company will monitor bid price and consider options, including a potential reverse stock split.
- No assurance that the company will regain compliance or that Nasdaq will grant an extension.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1856725/000095017025090384/0000950170-25-090384-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1856725/000095017025090384/rani-20250620.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-090384

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer